Abstract
Cardiolipidology – a new direction in cardiology – is developing intensively owing to the method of mass spectrometry. This method has acquired particular importance for the determination of molecular types of sphingolipids, the metabolism of which is closely related to the metabolism of cholesterol. Changes in the level of a number of sphingolipids claiming to be markers of cardiovascular diseases (CVDs) (molecular forms of sphingomyelins, ceramides, glucosylceramides, sphingosine, and sphinganin), in the blood plasma of patients with hereditary forms of early atherosclerosis (familial hyperlipidemia, FHL) were studied by chromatography–mass spectrometry. The study group (52 people) consisted of patients with acute manifestations of atherosclerosis, with postinfarction cardiosclerosis, and with dyslipidemia or early CVD. In patients with FHL, there was an increase in the proportion of long-chain sphingomyelin SM18:1/22:0 and the level of ceramides with carbon chains C20-1 and C22-1. An increase in the level of sphingosine, possessing proapoptotic properties, which can be considered as a marker of an additional risk of cardiovascular complications, was revealed in patients with a high clinical probability of FHL. The search for new CVD markers will improve personalized approach to the management of such patients and improve the results of their treatment.
Similar content being viewed by others
REFERENCES
Choi, R.H., Tatum, S.M., Symons, J.D., Summers, S.A., and Holland, W.L., Nat. Rev. Cardiol., 2021, vol. 18, no. 10, p. 701. https://doi.org/10.1038/s41569-021-00536-1
Alessenko, A.V., Lebedev, A.T., and Kurochkin, I.N., Biochemistry (Moscow), Suppl. Ser. B, 2019, vol. 13, p. 122. https://doi.org/10.1134/S1990750819020021
Cai, F., Ren, F., Zhang, Y., Ding, X., Fu, G., Ren, D., Yang, L., Chen, N., Shang, Y., Hu, Y., Yi, L., and Zhang, H.J., J. Chromatogr. B: Anal. Technol. Biomed. Life Sci., 2021, vol. 1169, 122603. https://doi.org/10.1016/j.jchromb.2021.122603
Alesenko, A.V., Zateishchikov, D.A., Lebedev, A.T., and Kurochkin, I.N., Kardiologiya, 2019, vol. 59, no. 8, p. 77. https://doi.org/10.18087/cardio.2019.8.10270
Zhang, D.X., Fryer, R.M., Hsu, A.K., Zou, A.P., Gross, G.J., Campbell, W.B., and Li, P.L., Basic Res. Cardiol., 2001, vol. 96, no. 3, p. 267. https://doi.org/10.1007/s003950170057
Lemaitre, P.N., Hoofnagle, A., McKnight, B., Fretts, A., King, I.B., Siscovick, D., Psaty, B.M., Heckbert, S.R., and Sotoodehnia, N., Circ Heart Failure, 2019, vol. 12, no. 7, e005708. https://doi.org/10.1161/CIRCHEARTFAILURE.118.005708
Tong, X., Peng, H., Liu, D., Ji, L., Niu, C., Ren, J., Pan, B., Hu, J., Zheng, L., and Huang, Y., Cardiovasc. Diabetol., 2013, p. 12, 27. https://doi.org/10.1186/1475-2840-12-27
Spijkers, L.J., Akker, R.F., Janssen, B.J., Debets, J.J., De Mey, J.G., Stroes, E.S., van den Born, B.J., Wijesinghe, D.S., Chalfant, C.E., MacAleese, L., Eijkel, G.B., Heeren, R.M., Alewijnse, A.E., and Peters, S.L., PLoS One, 2011, vol. 6, no. 7, e21817. https://doi.org/10.1371/journal.pone.0021817
Fenger, M., Linneberg, A., Jorgensen, T., Madsbad, S., Sobye, K., Eugen-Olsen, J., and Jeppesen, J., BMC Genet., 2011, vol. 12, p. 44. https://doi.org/10.1186/1471-2156-12-44
Gulati, S., Liu, Y., Munkacsi, A.B., Wilcox, L., and Sturley, S.L., Prog. Lipid Res., 2010, vol. 49, no. 4, p. 353. https://doi.org/10.1016/j.plipres.2010.03.003
Subbaiah, P.V., Gesquiere, L.R., and Wang, K., J. Lipid Res., 2005, vol. 46, p. 2699. https://doi.org/10.1194/jlr.M500263-JLR200
London, M.E., J. Biol. Chem., 2004, vol. 279, no. 11, p. 9997. https://doi.org/10.1074/jbc.M309992200
Slotte, J.P. and Bierman, E.L., Biochem. J., 1988, vol. 250, no. 8, p. 653. https://doi.org/10.1042/bj2500653
Leventhal, A.R., Chen, W., Tall, A.R., and Tabas, I., J. Biol. Chem., 2001, vol. 276, no. 48, p. 44976. https://doi.org/10.1074/jbc.M106455200
Merrill, A.Jr. and Sullards, M.C., Biochim. Biophys. Acta: Mol. Cell Biol. Lipids, 2017, vol. 1862, no. 8, p. 774. https://doi.org/10.1016/j.bbalip.2017.01.009
Han, X., Yang, K., and Gross, R.W., Mass Spectrom. Rev., 2012, vol. 31, p. 134. https://doi.org/10.1002/mas.20342
Lebedev, A.T., Mass-spektrometriya v organicheskoi khimii (Mass Spectrometry in Organic Chemistry), Moscow: Tekhnosfera, 2015.
Zaikin, V.G. and Borisov, R.S., Mass-Spektrom., 2021, vol. 18, no. 1, p. 4.
Han, X. and Gross, R.W., Mass Spectrom. Rev., 2005, vol. 24, p. 367. https://doi.org/10.1002/mas.20023
Xu, Y. and Brenna, J.T., Anal. Chem., 2007, vol. 79, p. 2525. https://doi.org/10.1021/ac062055a
Dreisewerd, K., Muthing, J., Rohlfing, A., Meisen, I., Vukelic, Z., Peter-Katalinic, J., Hillenkamp, F., and Berkenkamp, S., Anal. Chem., 2005, vol. 77, p. 4098. https://doi.org/10.1021/ac048373w
Porcari, A.M., Fernandes, G.D., Belaz, K.R.A., Schwab, N.V., Santos, V.G., Alberici, R.M., Gromova, V.A., Eberlin, M.N., Lebedev, A.T., and Tata, A., Anal. Methods, 2014, vol. 6, p. 2436.
Lebedev, A.T., Russ. Chem. Rev., 2015, vol. 84, no. 7, p. 665. https://doi.org/10.1070/RCR4508
Liu, X., Wang, J., Hu, B., Yan, P., Jia, S., Du, Z., and Jiang, H., J. Chromatogr. B: Anal. Technol. Biomed. Life Sci., 2021, vol. 1173, 122684. https://doi.org/10.1016/j.jchromb.2021.122684ectrometry
Sullards, M.C., Methods Enzymol., 2000, vol. 312, p. 32. https://doi.org/10.1016/s0076-6879(00)12898-8
Shaner, R.L., Allegood, J.C., Park, H., Wang, E., Kelly, S., Haynes, C.A., Sullards, M.C., and Merrill, A.H., J. Lipid Res., 2009, vol. 50, no. 8, p. 1692. https://doi.org/10.1194/jlr.D800051-JLR200
Kaya, I., Samfors, S., Levin, M., Boren, J., and Fletcher, J.S., J. Am. Soc. Mass Spectrom., 2020, vol. 31, p. 2133. https://doi.org/10.1021/jasms.0c00245
Sugiyama, E., Hara, A., Uemura, K., and Taketomi, T., Glycobiology, 1997, vol. 7, no. 5, p. 719. https://doi.org/10.1093/glycob/7.5.719
Chen, Y., Ying, LiuY., Sullards, M.C., and Merrill, A.H., Neuromol. Med., 2010, vol. 12, no. 4, p. 306. https://doi.org/10.1007/s12017-010-8132-8
Merrill, A.H., Jr., Sullards, M.C., Allegood, J.C., Kelly, S., and Wang, E., Methods, 2005, vol. 36, no. 2, p. 207. https://doi.org/10.1016/j.ymeth.2005.01.009
Houjou, T., Yamatani, K., Nakanishi, H., Imagawa, M., Shinuzu, T., and Taguchi, R., Rapid Commun. Mass Spectrom., 2004, vol. 18, p. 3123. https://doi.org/10.1002/rcm.1737
O’Connor, P.B., Budnik, B.A., Ivleva, V.B., Kaur, P., Moyer, S.C., Pittman, J.L., and Costello, C.E., J. Am. Soc. Mass Spectrom., 2004, vol. 15, no. 1, p. 128.
Forresterm, J.S., Milne, S.B., Ivanova, P.T., and Brown, H.A., Mol. Pharmacol., 2004, vol. 65, p. 813. https://doi.org/10.1124/mol.65.4.813
Han, X., Yang, J., Cheng, H., Ye, H., and Gross, R.W., Anal. Biochem., 2004, vol. 330, no. 2, p. 317. https://doi.org/10.1016/j.ab.2004.04.004
Domon, B. and Costello, C.E., Biochemistry, 1998, vol. 27, no. 5, p. 1534. https://doi.org/10.1021/bi00405a021
Yoo, H.H., Son, J., and Kim, D.H., J. Chromatogr. B: Anal. Technol. Biomed. Life Sci., 2006, vol. 843, no. 2, p. 327. https://doi.org/10.1016/j.jchromb.2006.06.025
Han, X. and Gross, R.W., J. Lipid Res., 2003, vol. 44, no. 6, p. 1071. https://doi.org/10.1194/jlr.R300004-JLR200
Jimenez-Rojo, N., Viguera, A.R., Collado, M.I., Sims, K.H., Constance, C., Hill, K.S., Shaw, W.A., Goni, F.M., and Alonso, A., Biochim. Biophys. Acta, 2014, vol. 1838, no. 8, p. 2071. https://doi.org/10.1016/j.bbamem.2014.04.028
Funding
This work was supported by the Russian Foundation for Basic Research, project no. 19-04-00870A “Sphingolipidome analysis of markers of cardiovascular diseases.”
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
The authors declare that they have no conflicts of interest.
Additional information
Translated by V. Kudrinskaya
Rights and permissions
About this article
Cite this article
Alessenko, A.V., Shupik, M.A., Gutner, U.A. et al. Prospects for Using Chromatography–Mass Spectrometry for the Determination of Lipids in Clinical Cardiolipidology. J Anal Chem 77, 439–449 (2022). https://doi.org/10.1134/S1061934822040025
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1061934822040025